EXPERT VIEWS
Display All Commentary
Sentiment Indicator
0.8
No. Of Recommendations
4
BROKER
DATE
RATING
RECOMMENDATION
TARGET PRICE
% TO REACH TARGET
UBS
13/10/2023
1
Upgrade to Buy from Neutral
$8.00
17.30%
- COMMENTARY
Given both share price weakness and recovery in rare earth pricing, UBS has lifted its rating on Lynas Rare Earths. The company's stock has declined -10% since July, as rare earth prices have climbed 22%.
For the broker, ramp-up at the Kalgoorlie site remains a risk, but the company does guide to first mixed rare earth concentrate from September.
The rating is upgraded to Buy from Neutral and the target price of $8.00 is retained.
FORECAST
UBS forecasts a full year FY24 EPS of 12.00 cents.
UBS forecasts a full year FY25 EPS of 44.00 cents.Macquarie
30/08/2023
1
Outperform
$7.70
12.90%
- COMMENTARY
FY23 earnings from Lynas Rare Earths were broadly in line with Macquarie's estimates. The broker increases expenditure estimates for Kalgoorlie to match the company's revised project guidance of -$730m as costs escalated.
The major de-risking event will be achieving first production at Kalgoorlie, expected in the September quarter. Macquarie also lifts estimates for Mount Weld capital expenditure by 20% to -$600m. Outperform retained. Target is steady at $7.70.
FORECAST
Macquarie forecasts a full year FY24 dividend of 0.00 cents and EPS of 41.50 cents.
Macquarie forecasts a full year FY25 dividend of 0.00 cents and EPS of 75.50 cents.Citi
30/08/2023
3
Neutral
$7.35
7.77%
- COMMENTARY
FY23 EBITDA beat Citi's estimates. On further analysis of the results the broker upgrades earnings estimates by 17% for FY24 and by 3% for FY25 because of lower operating costs and higher financial income.
This is slightly offset by downward adjustments to rare earths prices and sales volumes. The broker points out prices remain relatively depressed, with current spot prices implying FY24 earnings down -70%. Neutral retained. Target is reduced to $7.35 from $7.60.
FORECAST
Citi forecasts a full year FY24 dividend of 0.00 cents and EPS of 26.30 cents.
Citi forecasts a full year FY25 dividend of 0.00 cents and EPS of 44.30 cents.Bell Potter
30/08/2023
1
Buy
$8.50
24.63%
- COMMENTARY
Lynas Rare Earths FY23 results saw profit ahead of Bell Potter on revenue below and a higher cost of goods sold. FY23, by all intents and purposes was a successful year, the broker suggests.
This is despite production issues and weaker NdPr prices. Production of NdPr increased 4% year on year to an all-time record, beating Bell Potter's numbers.
The immediate future is a little murkier as costs are likely to remain at current levels or higher as operations transition to Kalgoorlie
from Malaysia. Finished product stockpiling will continue over the first half which should smooth the sales profile over FY24.Lynas is a high-quality business, Bell Potter suggests, and a key supplier of separated rare earths to Western economies. The broker sees the business as being well placed to weather any issues as it transitions operations over the next six months.
Target rises to $8.50 from $7.80, Buy retained.
FORECAST
Bell Potter forecasts a full year FY24 dividend of 0.00 cents and EPS of 31.90 cents.
Bell Potter forecasts a full year FY25 dividend of 0.00 cents and EPS of 43.50 cents.
- Forums
- ASX - By Stock
- LYC
- Ann: Annual Report FY2023
LYC
lynas rare earths limited
Add to My Watchlist
1.43%
!
$9.20

Ann: Annual Report FY2023, page-12
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$9.20 |
Change
0.130(1.43%) |
Mkt cap ! $8.606B |
Open | High | Low | Value | Volume |
$9.06 | $9.31 | $8.96 | $20.49M | 2.226M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5955 | $9.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.21 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5955 | 9.170 |
1 | 1200 | 9.160 |
1 | 56 | 9.150 |
1 | 10637 | 9.140 |
1 | 3000 | 9.130 |
Price($) | Vol. | No. |
---|---|---|
9.210 | 1000 | 1 |
9.230 | 25573 | 3 |
9.240 | 14854 | 2 |
9.250 | 22687 | 6 |
9.270 | 15137 | 2 |
Last trade - 16.19pm 26/06/2025 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online